Related Experiment Video

Updated: Jul 11, 2026

Tuina Intervention in Sodium Monoiodoacetate Injection-Induced Rat Model of Knee Osteoarthritis
06:14

Tuina Intervention in Sodium Monoiodoacetate Injection-Induced Rat Model of Knee Osteoarthritis

Published on: January 12, 2024

Osteoarthritis management of the knee--treatment options post the NSAID cardiotoxicity controversy

Jan Gartlan1, Mark Nelson, Graeme Jones

  • 1Menzies Research Institute, University of Tasmania, Australia. janette.gartlan@utas.edu.au

Australian Family Physician
|September 22, 2007
PubMed

Insights

This article reviews knee osteoarthritis treatments following concerns about NSAID cardiotoxicity. It provides general practitioners with evidence-based options for managing knee osteoarthritis.

Area of Science:

  • Orthopedics
  • Rheumatology
  • General Practice

Background:

  • The Cochrane Musculoskeletal Group (CMSG) facilitates articles for general practitioners.
  • Recent Cochrane reviews on musculoskeletal conditions are contextualized for primary care.
  • This article focuses on knee osteoarthritis management.

Observation:

  • The 'NSAID cardiotoxicity controversy' has impacted treatment decisions.
  • Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used for osteoarthritis.
  • Patient safety concerns necessitate alternative or modified treatment strategies.

Findings:

  • Evidence-based treatment options for knee osteoarthritis are presented.
  • The article synthesizes findings from recent Cochrane musculoskeletal reviews.
  • Management strategies consider the risks associated with NSAIDs.

Implications:

  • General practitioners can utilize this information for informed patient care.
  • This resource supports evidence-based decision-making in knee osteoarthritis management.
  • It addresses a critical clinical challenge in primary care settings.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...